information system, prospective audits of the intervention systems used, feedback, formulary restriction, preauthorization, and the development of a computer management system. An effective health information system can result in reduced antimicrobial resistance. Taiwan CDC encourages hospitals to establish an effective health information system for prospective audits of direct intervention and feedback to the prescriber. An effective health information system includes the mechanisms and functions of surveillance, can investigate the use of antibiotics, perform internal audits, evaluate antimicrobial agents, deal with inappropriate orders, and suggest alternative therapies. The prescribing physicians will be contacted if their orders are evaluated as inappropriate. Feedback might be provided as a verbal or -like  12  54  12  68  12  79  10  119 9  267 9  256  9  246 9  230  Other  1173  1183  1086  859  1417  1470  1426  1649  Total  5232  5408  4863  4067  6556  7074  6637  7429 a NOS, not otherwise specified. 
Healthcare-associated infection and antimicrobial resistance in Taiwan
Healthcare-associated infection (HAI) and antimicrobial resistance are current challenges to the treatment of infectious diseases in Taiwan. 5e11 Taiwan nosocomial infection surveillance system (TNIS), 12 a nationwide surveillance study on the incidence and prevalence of HAI and antimicrobial resistance in Taiwan during 2003e2010, 13 reported that the HAI incidence rates (number of HAIs/number of patient-days Â 1000%) in the intensive care units (ICUs) of medical centers and regional hospitals has decreased significantly from 12.8% to 8.2% (P Z 0.002) (Fig. 1A) . HAI incidence rates in medical centers and regional hospitals decreased significantly from 4.1% to 2.7% (P Z 0.003) (Fig. 1B) . The proportion of site-specific HAIs in ICUs and regional hospitals are shown in Fig. 2A and Fig. 2B , respectively. In 2010, blood stream infections topped the list in the ICUs of medical centers, followed by urinary tract infections and pneumonia. Urinary tract infections topped the list in the ICUs of regional hospitals, followed by bloodstream infections and pneumonia in 2010. The proportion of blood stream infections increased significantly in the ICUs of medical centers (p < 0.0001) and regional hospitals (p Z 0.0039) during 2003e2010. The common pathogens associated with HAIs in these ICUs are shown in Table 1A and B. In 2010, the top three pathogens in the ICUs were Candida species, Acinetobacter baumannii, and Pseudomonas aeruginosa in medical centers; A baumannii, Candida species, and Klebsiella pneumoniae were the most common in regional hospitals. In the ICUs of medical centers and regional hospitals in 2010, the proportion of methicillin resistance in Staphylococcus aureus (MRSA) isolates was 76.6%, vancomycin resistance in enterococcal isolates (VRE) was 20.2%, imipenem or meropenem resistance in A baumannii isolates (carbapenemresistant A baumannii; CRAB) was 70.1%, imipenem or meropenem resistance in P aeruginosa isolates (carbapenem-resistant P aeruginosa; CRPA) was 19.0%, carbapenem resistance in Enterobacteriaceae isolates (CRE) was 5.0%, carbapenem resistance in E coli isolates (CREC) was 2.2%, and carbapenem resistance in K pneumoniae isolates (CRKP) was 8.7%. 
Impact of antimicrobial stewardship programs
Antimicrobial stewardship programs (ASPs) have the potential to reduce antimicrobial resistance, healthcare costs, and drug-related adverse events by improving clinical outcomes.
14e16 During 1988e2001, New York Hospital Queens has taken a series of management steps to address antimicrobial resistance, including monitoring ceftazidime and imipenem resistance in Gram-negative bacteria, providing infectious disease consultation and health education, and limiting the use of cephalosporins and cephamycins. This resulted in an 80% reduction in the use of cephalosporincephamycin, 44% reduction in Klebsiella species isolates resistant to ceftazidime, and 87% reduction in a surgical ICU. 17 Drew et al reported a reduction in the use of antibiotics at Chandler Medical Center in Kentucky after performing a prospective audit with intervention and feedback. 18 They also reported a 30% reduction in the cost of antimicrobials. Furthermore, formulary restriction and the preauthorization of prescriptions have significantly reduced the use of antibiotics and medical costs at Chandler Medical Center since 1991, reduced the use of ceftazidime, cefotaxime, and ceftriaxone by 80% in 2002, and also decreased the resistant rates of several important pathogens, including multidrug-resistant P aeruginosa and MRSA.
ASP in Taiwan
Based on the abovementioned studies, ASPs are considered to have significant and supporting scientific evidence. Taiwan's ASP, in reference to the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA) guidelines (a hospital pharmacy guide), and WHO's global strategy for the containment of antimicrobial resistance to ASPs, 3, 4, 19, 20 has adopted scientific approaches and emphasizes the impact of resistance to antimicrobial agents. These approaches include the appropriate selection of dosage, route of administration, and duration of antimicrobial therapy. The objectives of ASP in Taiwan are to strengthen the monitoring and surveillance systems used to prevent the spread of antimicrobial-resistant bacteria, maximize favorable outcomes, and minimize antimicrobial resistance after antibiotic use. Regarding patient safety concerns, Taiwan's ASP combines hospital infection control measures, such as hand hygiene and care bundles, that might control the emergence and spread of antimicrobial resistance. Taiwan's ASP operates as follows ( Table 2) .
Establishment of national inter-sectoral antimicrobial stewardship task force 3, 4 The implementation of a government's health policy and healthcare system is a key element to determining the efficiency of interventions. Also, national commitment and problem-solving skills are thought to be essential. To reduce antimicrobial-resistant bacteria and lower the occurrence of healthcare-associated infections, the Centers for Disease Control, R.O.C (Taiwan CDC) has put a lot of effort into making the containment of drug resistance a national priority. As a result, the national inter-sectoral antimicrobial stewardship task force was established that included physicians, infection control professionals, clinical microbiologists, information system specialists, nurses, clinical pharmacists, healthcare professionals, veterinarians, agriculturalists, pharmaceutical manufacturers, government representatives, media representatives, consumers, and other stakeholders. The aims of the task force were to increase the recognition of antimicrobial resistance, to reduce the inappropriate spread of antimicrobial-resistant bacteria, to establish a well-organized data-collection process, to facilitate the implementation of interventions such as education and surveillance, to develop indicators to assess the impact of drug-resistance policies, to reduce unnecessary medical costs, and to improve the quality of the medical services provided.
Antimicrobial-resistance management strategies
The core management strategies against antimicrobial resistance include the development of an effective health written notice. 18e20 The results of surveillance should be immediately reported back to clinicians so they can revise drug use. Formulary restriction, preauthorization, and computer management system requirements involve the development of a thorough computer management system, restricting the use of some particular antimicrobial agents to specific indications, periods of therapy, disease severity, physician services, prescribers, or patient populations. The features of this restriction depend on certain factors, such as institutional antimicrobial resistance and patient safety issues related to the antimicrobial agents in question. 15, 19, 21, 22 The prospective audit with intervention and feedback, as well as the formulary restrictions and preauthorizations given to certain prescriptions by infection control physicians and clinical pharmacists with infectious disease training, can reduce inappropriate antibiotic use and additional medical costs by implementing antibioticmanagement programs. 20 In order to urge hospitals to develop and implement strategies that address antibiotic control, Taiwan CDC has implemented a "core management strategy of antibiotic resistance" through audit mechanisms of hospital accreditation, 23 infection control inspection, 24 and the national health insurance payment system. 25 In relation to the standard criteria of hospital accreditation and hospital infection control inspections, standard criteria related to antibiotic management are shown in Table 3 .
Supplemental antimicrobial-resistance management strategies
Supplemental strategies can play a crucial role in ASPs. 20, 26 In order to lower the incidence of HAIs and prevent the spread of antimicrobial resistance within medical institutions, the following actions were listed as supplemental antimicrobial-resistance strategies by Taiwan CDC. These include preservice and in-service education programs that present related knowledge regarding the spread of multidrug-resistant microorganisms and the multidisciplinary development of evidencebased practice guidelines 27, 28 and clinical pathways, 26, 29 computerized physician-order entry, antimicrobial order forms, 30 real-time information systems, computerized decision-support systems, the streamlining or de-emphasis of empirical antimicrobial therapy based on culture 
Correct use of prophylactic antibiotics in hospitals.
Use of prophylactic antibiotics should be listed in the medical record, and hospital inspectors should review the medical records at random. 2.1. The first dose of the prophylactic antibiotic should be given within 1 hour before the surgical incision if the use of prophylactic antibiotic is required (e.g., for cesarean section, prophylactic antibiotics should be given immediately after umbilical ligation excision). 2.2. Drug selection should be consistent with the guidelines for antibiotic use in Taiwan. 2.3. The antibiotic dose should be consistent with the patient's weight. 2.4. Additional antibiotics should be given as necessary during a surgery (with consideration of the pharmacokinetics). 2.5. Discontinue the use of antibiotics after clean surgery. Antibiotics should be used for less than 24 hours after major surgery. 2.6. Set up monitoring and improve the mechanisms for the effective use of prophylactic antibiotics.
Reasonable antibiotics use in outpatients.
Hospital inspectors should review the medical records at random. 3.1. Use antibiotics only if it is required. Detailed explanations should be written on the medical record when using antibiotics. 3.2. Antibiotics cannot be used for treating the common cold. 3.3. Rational use of the types and dosages of antibiotics with consideration of the patient's weight and kidney functions. 3.4. Use antibiotics for a rational period of time. Detailed explanations should be written to explain any irregularities. 3.5. Monitoring and improve the mechanisms for the effective use of antibiotics in outpatients.
Effective management and reporting of multi-drug resistance bacteria in hospitals.
4.1. Based on the bacterial isolate and the type of ward, responsible infection control staff, clinicians, and nurses can control the isolates, especially antimicrobial-resistant bacteria such as CRAB, VRE, MRSA, and CRE. Analytical reports should include the isolated strain and antibiotic sensitivity.
results, the elimination of redundant combination therapies, 31 ,32 optimization of antimicrobial dosing based on individual patient characteristics, causative organism, site of infection, pharmacokinetic and pharmacodynamic characteristics of the drug, and a systemic plan for parenteral to oral conversion of antimicrobials. 33, 34 Besides, these were incorporated into the standard criteria of hospital accreditation, hospital infection control inspection, as well as audits of national health insurance payments. The aim is to supervise and urge hospitals to establish appropriate mechanism for antibiotic use with effective implementation.
Surveillance of HAI and antimicrobial resistance
The surveillance of antimicrobial resistance is fundamental to the effective implementation of any strategy for the containment of antimicrobial resistance because it is the means by which physicians can monitor the efficacy of various interventions. Taiwan CDC established TNIS to monitor HAI and antimicrobial resistance. Taiwan CDC adopted voluntary participation, in reference to the HAI surveillance mechanism of Europe 35 and USA. 36 This surveillance mechanism has been extended to all levels of hospitals since the ICUs of medical centers began to report their findings at the end of 2001. In order to understand the trends of multidrug-resistant strains, Taiwan CDC undertook the monitoring of HAI and antimicrobial resistance. The current TNIS has enrolled more than 300 hospitals, of which more than 70 hospitals report cases through an information exchange center. 12 This surveillance system, which utilizes standard tables for data analysis, can report back to individual hospitals their own analysis tables on HAI, antimicrobial resistance, the distribution of pathogens, and antibiotic resistance. In order to analyze, interpret, and apply the HAI and antimicrobial resistance data, the HAI and antimicrobial-resistance data-analysis task force under Taiwan's Healthcare Infection Control Practices Advisory Committee (Fig. 3) was set up and the results of the analysis were distributed to hospitals for reference and other documents, journals, and reference channels were provided. The feedback mechanisms of the regular data analysis provide self-monitoring within the hospitals and reference to hospitals at the same level. The committee will also continue to review and improve the surveillance reporting system in order to improve data validation, accuracy, and completeness, which should help both the government and the hospitals effectively use the national surveillance data.
Control of hospital infections
Poor compliance with infection control measures in any setting can greatly increase the spread of drug-resistant bacteria, especially during outbreaks. Collaboration between the ASP and hospital infection control programs is essential. 4, 22, 37 The combination of effective antimicrobial stewardship with a comprehensive infection control program has been shown to limit the emergence and transmission of antimicrobial-resistant bacteria. 38 The following actions were listed as the main strategies for infection control by Taiwan CDC: to promote hand hygiene in healthcare facilities 39 and communities; to conduct a project entitled "care bundle to lower HAIs"; to establish guidelines 40 for infection control measures and contact precautions 40 ; to strengthen aseptic practices, sterilization, and disinfection 41 ; to promote environmentally friendly hygiene and waste management procedures; and to facilitate environmental designs for appropriate infection control practices. 42 Among those strategies, continuing to promote hand hygiene in healthcare facilities and communities and conducting a project entitled "care bundle to lower the HAIs" are two of the top priorities of Taiwan CDC. These initiatives are described below.
Promotion of hand hygiene
Ensuring good hand hygiene is key to preventing the spread of infections and bringing disease outbreaks under control. 43, 44 In order to effectively prevent HAIs, a theme promoting hand hygiene was planned based on the "Clean Care is Safer Care" initiative of Patient Safety Alliance (WHO). 45 Three medical centers (National Taiwan University Hospital, Kaohsiung Veterans General Hospital, and Tri-service General Hospital) were chosen as hand-hygiene demonstration centers by Taiwan CDC. The goal is to achieve hospital-wide participation, including involvement at the management level and patient participation. At the same time, the culture of patient safety was formed through the creation of a nationwide hand-hygiene certification and reward system that might increase the 4.2. Reports on antibiotic susceptibility of clinically isolated strains should be edited annually. The latest statistical reports should be distributed to every physician or announced through the internet in order to allow physicians to check these reports at any time. 4.3. Consideration of patient privacy, mark and proper isolation should effectively be done for those with specific antimicrobial resistant infection or colonization. 4.4. Statistical reports regarding bacterial isolates of HAI should be performed at least every 6 months. These should be distributed to physicians and related staff or be made public through the internet. 4.5. Strains, isolates, and analytical reports on inpatients should be provided to healthcare staff as reference. 4.6. Multidrug resistant-related data should be reported to Taiwan CDC per their policy. 4.7. Set up relative mechanisms and make sure each physician understands related information. 4.8. Analyze the trends in antimicrobial resistance and antibiotic use every 6 months. 4.9. Based on the report, related policies should be implemented to improve the control of VRE, MRSA, CRAB, CRE, and others.
accessibility of hand-hygiene equipment and hand-hygiene recognition by healthcare workers. Furthermore, continuous hospital quality improvements and effective implementation of hand hygiene can be encouraged through assessment, performance indicators, and audit mechanisms of both the hospital accreditation process and hospital infection inspections. 56 , and antibiotic care bundles for lowering multidrug resistant bacteria infections, such as MRSA, VRE, and CRAB.
Promotion of care bundle: multimodal infection control measures and interventions

Pharmaceutical affairs and infection control regulations
The Pharmaceutical Affairs Act was amended in 2005 by the Taiwan Food and Drug and Administration (TFDA), 57 and this act clearly attempts to regulate the sale, supply, and dispensing of prescriptions in order to ensure that antimicrobials meet the international standards of quality, safety and efficacy. The Communicable Disease Control Act, which was amended in January 2004, clearly states that medical institutions should prevent the occurrence of HAI. 57, 58 In November 2004, the "regulation for communicable disease control and vaccination measures in health/ medical institutions" was promulgated. In January 2008, the title was amended as the "implementation and inspection of infection control measures for medical institutions," and the amended document clearly indicates that medical institutions should implement infection control measures and standard items for inspection by competent authority. Audit mechanism of hospital accreditation, inspection, and national health insurance payment system
The existence of appropriate legislation regarding antimicrobial agents and infection control cannot improve the quality of infection control and use of antibiotics unless enforced. To reduce HAIs and antimicrobial resistance, the standard criteria for hospital infection control inspection have been published by the central health authority every year since 2005, and a local health officer is responsible for the inspection of hospitals within each area. Improvements have been made to the hospital infection control program since 2008; infection control experts were allocated to assist local health officers and evaluate the infection control practices. This program involves the integration of standard criteria for hospital infection control inspection and hospital infection control accreditation and the establishment of a fair audit mechanism. The latter includes the results of hospital infection control inspections into hospital infection control accreditation and national health insurance payment system as references. In 2011, there were a total of 10 items and 31 secondary items listed in the standards for infection control inspection.
HAIs and antimicrobial resistance are two of the most preventable leading causes of mortality. These infections also add a significant economic burden to the healthcare system. Taiwan CDC is responsible for supervising medical institutions and establishing a robust and organized infection control framework. Potential measurements include, for example, the application of healthcare information technology to antimicrobial stewardship, establishment of infection control committees and dedicated units, and the allocation of physicians and nurses to address infection control, antibiotic regulations, and the promotion of these practices.
Taiwan CDC, in conjunction with infectious diseases physicians, infectious control experts, and other multidisciplinary experts, conducts antimicrobial stewardship and infection control programs through the audit mechanisms of hospital accreditation, hospital inspection, and the national health insurance payment system to reduce, prevent, and eventually eliminate most of the significant burden to our national health system. The Taiwanese government also encourages drug development programs to foster the innovation, research, and development of new tools that work to reduce the financial incentives that encourage the irrational use of medicine, i.e., "No action today, no cure tomorrow." Taiwan CDC makes every effort to combat antimicrobial resistance by targeting consumers, prescribers, dispensers, veterinarians, managers of hospitals and diagnostic laboratories, patients and visitors to healthcare facilities, as well as national governments, the pharmaceutical industry, professional societies, and international agencies.
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